CEO Brian Tyler disclosed the sale of 8,961 shares at an average price of $597.99 for a total amount of $5.36M. The share sales ...

McKesson Corp. closed 4.98% short of its 52-week high of $637.51, which the company achieved on August 2nd.

Baird analyst Eric Coldwell designated McKesson (MCK) as a Bullish Fresh Pick. Baird maintains its Outperform rating and $730 price target on McKesson shares. Published first on TheFly – the ...

McKesson Corp. closed 6.87% below its 52-week high of $637.51, which the company reached on August 2nd.

McKesson (NYSE:MCK) is one of the three main drug distribution firms in the United States. The company has more than 50,000 employees and generates around $350 billion in annual revenues ...

IRVING, Texas, February 05, 2025--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2025 third quarter financial results. Results can be accessed on McKesson’s Investor ...

Based in Irving, Texas, McKesson Corporation (MCK) is a leading healthcare distribution and services company. With a market ...

The investment community will be closely monitoring the performance of McKesson in its forthcoming earnings report. The company is scheduled to release its earnings on February 5, 2025.

IRVING, Texas (AP) — IRVING, Texas (AP) — McKesson Corp. (MCK) on Wednesday reported fiscal third-quarter earnings of $879 million. The Irving, Texas-based company said it had profit of $6.95 ...

McKesson is a significant player in the healthcare supply chain, providing medical supplies and pharmaceutical products across various regions. The company is essential in the U.S. Pharmaceutical ...

The institutional investor owned 1,330 shares of the company’s stock after selling 79,764 shares during the quarter. SG Americas Securities LLC’s holdings in McKesson were worth $758,000 at ...